Literature DB >> 19690889

Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.

Qiaoli Li1, Ying Zhou, Chenjiang Yao, Xiaoping Ma, Lianyun Wang, Wangjie Xu, Zhaoxia Wang, Zhongdong Qiao.   

Abstract

The role of heat shock protein 90 inhibitor geldanamycin (GA) during Leishmania donovani promastigote-to-amastigote transformation in axenic conditions was investigated. Promastigotes exhibited apoptotic morphologic changes after GA treatment at a high temperature, and the effect is in a dose- and time-dependant manner. Meanwhile, cell cycle analysis showed a significant increase at the expense of cells in the G0/G1 phase and a decrease in the S and G2/M phases after GA treatment. In addition, cellular glutathione level was reduced and reactive oxygen species content was increased afterwards. Pretreatment with antioxidants reduced the percentage of GA-induced cell apoptosis. After treatment, cultures in pH 5.5 showed a lower percentage of apoptosis than those in pH 7.4. The present study showed that GA could cause apoptosis in L. donovani but could not cause stage differentiation in high temperature and that acidic conditions were likely to be crucial for the transformation and survival of the parasite within its human host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690889     DOI: 10.1007/s00436-009-1582-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

1.  The heat shock protein 90 of Leishmania donovani.

Authors:  M Wiesgigl; J Clos
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

Review 2.  Hsp90 & Co. - a holding for folding.

Authors:  J Buchner
Journal:  Trends Biochem Sci       Date:  1999-04       Impact factor: 13.807

3.  Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro.

Authors:  K P Chang; D M Dwyer
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

4.  Chemical Stress does not Induce Heat Shock Protein Synthesis in Leishmania donovani.

Authors:  J Clos; S Brandau; C Hoyer
Journal:  Protist       Date:  2009-07-13

5.  Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation.

Authors:  Sebastian E B Graefe; Martina Wiesgigl; Iris Gaworski; Andrea Macdonald; Joachim Clos
Journal:  Eukaryot Cell       Date:  2002-12

6.  Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.

Authors:  Yuan-Yuan Tian; Li-Jia An; Lan Jiang; Yan-Long Duan; Jun Chen; Bo Jiang
Journal:  Life Sci       Date:  2006-09-20       Impact factor: 5.037

7.  Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani.

Authors:  M Wiesgigl; J Clos
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

8.  Mitochondrial superoxide mediates heat-induced apoptotic-like death in Leishmania infantum.

Authors:  Juan F Alzate; Andrés A Arias; David Moreno-Mateos; Alberto Alvarez-Barrientos; Antonio Jiménez-Ruiz
Journal:  Mol Biochem Parasitol       Date:  2007-01-09       Impact factor: 1.759

9.  Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.

Authors:  Navin K Verma; Gaganmeet Singh; Chinmoy S Dey
Journal:  Exp Parasitol       Date:  2006-12-11       Impact factor: 2.011

10.  Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity.

Authors:  Ashish Mehta; Chandrima Shaha
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

View more
  15 in total

Review 1.  Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

2.  Potent antitrypanosomal activities of heat shock protein 90 inhibitors in vitro and in vivo.

Authors:  Kirsten J Meyer; Theresa A Shapiro
Journal:  J Infect Dis       Date:  2013-04-22       Impact factor: 5.226

3.  Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor.

Authors:  Kercia P Cruz; Beatriz F C Patricio; Vinícius C Pires; Marina F Amorim; Alan G S F Pinho; Helenita C Quadros; Diana A S Dantas; Marcelo H C Chaves; Fabio R Formiga; Helvécio V A Rocha; Patrícia S T Veras
Journal:  Front Chem       Date:  2021-05-13       Impact factor: 5.221

4.  Nuclear translocation and accumulation of glyceraldehyde-3-phosphate dehydrogenase involved in diclazuril-induced apoptosis in Eimeria tenella (E. tenella).

Authors:  Congcong Wang; Chunzhou Han; Tao Li; Dehao Yang; Xiaojiong Shen; Yinxin Fan; Yang Xu; Wenli Zheng; Chenzhong Fei; Lifang Zhang; Feiqun Xue
Journal:  Vet Res       Date:  2013-05-07       Impact factor: 3.683

5.  Impact of protozoan cell death on parasite-host interactions and pathogenesis.

Authors:  Carsten Gk Lüder; Jenny Campos-Salinas; Elena Gonzalez-Rey; Ger van Zandbergen
Journal:  Parasit Vectors       Date:  2010-12-02       Impact factor: 3.876

6.  Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death.

Authors:  Despina Smirlis; Michael Duszenko; Antonio Jiménez Ruiz; Effie Scoulica; Patrick Bastien; Nicolas Fasel; Ketty Soteriadou
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

7.  17-AAG kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages.

Authors:  Antonio Luis de Oliveira Almeida Petersen; Carlos Eduardo Sampaio Guedes; Carolina Leite Versoza; José Geraldo Bomfim Lima; Luiz Antônio Rodrigues de Freitas; Valéria Matos Borges; Patrícia Sampaio Tavares Veras
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

8.  Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.

Authors:  Juan Carlos Pizarro; Tanya Hills; Guillermo Senisterra; Amy K Wernimont; Claire Mackenzie; Neil R Norcross; Michael A J Ferguson; Paul G Wyatt; Ian H Gilbert; Raymond Hui
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

Review 9.  A review of recent patents on the protozoan parasite HSP90 as a drug target.

Authors:  Sergio O Angel; Mariana Matrajt; Pablo C Echeverria
Journal:  Recent Pat Biotechnol       Date:  2013-04

10.  Identification of two novel HSP90 proteins in Babesia orientalis: molecular characterization, and computational analyses of their structure, function, antigenicity and inhibitor interaction.

Authors:  Muhammad Kasib Khan; Lan He; Weichao Zhang; Yifan Wang; Qing Tao; Qiqi Song; Muhammad Sohail Sajid; Qian Yu; Jinfang Hu; Rui Fang; Min Hu; Yanqin Zhou; Junlong Zhao
Journal:  Parasit Vectors       Date:  2014-06-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.